Skip to main content
. 2022 Nov 10;13(12):1856–1863. doi: 10.1021/acsmedchemlett.2c00213

Table 2. Antiproliferative Activities on the Proliferation of Ba/F3 Cell Lines of EGFR(L858R), EGFR(L858R/T790M), and Wild-Type HER2a.

  Cellular (Ba/F3) antiproliferative activity EC50 (nM)
Compound EGFR(L858R) EGFR(L858R/T790M) WT HER2
Lazertinib 4.8 ± 2 7.4 ± 1 >100
Osimertinib 3.2 ± 0.3 14 ± 4 34 ± 8
LN2057 0.51 ± 0.08 21 ± 5 2.7 ± 1
a

EC50 values are averages of at least three independent experiments with each experiment performed in triplicate. Errors are reported as ± standard deviation.